Osseon® Therapeutics Announces Another VCF Product

SANTA ROSA, Calif., June 14, 2013 /PRNewswire/ — Osseon® announces the release of the Osseoflex® CD-H hydraulic cement delivery system. This latest addition to the Osseon product line is designed for delivery of medium to high viscosity bone cement during the treatment of vertebral compression fractures (VCF). The Osseoflex® CD-H hydraulic cement delivery system complements Osseon’s family of steerable vertebral augmentation devices.

The Osseoflex® CD-H hydraulic cement delivery system is an improvement on other bone cement delivery systems, enabling precise, controlled delivery of bone cement when filling a cavity in a vertebra.

Osseon is also offering for those physicians who prefer a higher viscosity cement, a new, more viscous PMMA bone cement, which provides double the working time of lower viscosity cements.

The first vertebral augmentation cases have been performed with Osseon’s new Osseoflex® CD-H hydraulic cement delivery system by Paul Fuchs, MD of Orthopedic Specialists of SW Florida in Fort Meyers, FL, and Chad Hartley, MD of Panacea Brain & Spine in Lake Havasu City, AZ.

Osseon continues to develop innovative products which address both physician and patient needs for the treatment of vertebral compression fractures.

About Osseon:
Osseon® Therapeutics, Inc., headquartered in Santa Rosa, CA, is dedicated to developing and commercializing state of the art medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures. The company’s patented, steerable delivery system offers more treatment options than other commercial solutions as well as offering significant advantages in procedural efficiency and cost. By improving the treatment of compression fractures within the lower portion of the thoracic and the entire lumbar vertebral spine, Osseon offers new, forward thinking solutions to patients suffering from these maladies, as well as to the physicians and medical facilities that treat them. Osseon’s products are distributed globally.

For more information, visit our website at osseon.com.

Osseon® is a registered trademark of Osseon Therapeutics, Inc. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.


SOURCE Osseon Therapeutics, Inc.

Print Friendly, PDF & Email

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button